Atalanta Therapeutics
atalantatx.comLocations
Boston, MA, USA · West Street / River Street, Boston, MA, USA
industry
Biotechnology
Size
51-200 employees
Stage
Series B
founded in
2018
We are a biotechnology company pioneering new treatment options for neurodegenerative diseases by utilizing our proprietary RNA interference platform. We were founded by Anastasia Khvorova, Ph.D., Craig Mello, Ph.D., and Neil Aronin, M.D., of the RNA Therapeutics Institute at the University of Massachusetts Medical School, with a Series A funding exclusively by F-Prime Capital. We are headquartered in Boston, Mass.
Something looks off?Open jobs at Atalanta Therapeutics
On-site & Remote
Seniority
Salary